Director of Rheumatology Department, Chief Physician, Doctor of Medicine.
Affiliated HospitalRenji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
→
Research Areas : Complex and critical inflammatory rheumatic and immunological diseases, particularly SLE and dermatomyositis complicated with interstitial lung disease. Cutting-Edge Technologies: Led the clinical exploration of CD19/BCMA dual-target autologous CAR-T cell therapy for refractory SLE, achieving the first patient to achieve 104 weeks of drug-free clinical remission; spearheaded VA ECMO treatment for severe lupus patients. Areas of Expertise: SLE (prevention and treatment of various target organ injuries and relapses), dermatomyositis (MDA5-related interstitial pneumonia), and hyperinflammatory syndromes. Academic Highlights: Member of the Chinese Rheumatology Society; published over 40 SCI papers in journals such as NEJM, Lancet Rheumatology, and Annals of the Rheumatic Diseases; awarded the title of Shanghai Medical Craftsman.